Social Media Ideas for Sirna

Latest updates for Sirna

Fresh curated links around siRNA are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Post angles to try

Share the most useful takeaway for your audience.

Turn one article into a quick practical checklist.

Ask your audience how this shift affects their work.

Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

rna-seqblog.com /1 month ago

Small RNA sequencing reveals regulatory roles for sdRNAs in acute myeloid leukemia

Small RNA sequencing reveals cell-specific sdRNA patterns in AML and healthy hematopoiesis, linking certain snoRNA-derived RNAs to gene regulation and poorer patient outcomes...

Read source

nanowerk.com /1 month ago

DNA nanocircuit checks three tumor signals before releasing siRNA

A DNA carrier checks several tumor clues before releasing its treatment, helping spare healthy cells and making chemotherapy work better in resistant brain tumors.

Read source

genengnews.com /1 month ago

RNAV8 Bio Joins ARPA-H Team to Pioneer Programmable RNA Medicines

The PROPEL program aims to control gene expression through RNA structure, building logic-gated RNA therapies that switch on only where and when intended, without altering the genom...

Read source

biopharmadive.com /6 days ago

Next-gen RNAi drugmaker City prices $200M IPO

The offering will support a trio of medicines in or nearing clinical testing, as well as earlier research into RNAi treatments that get into tissues outside the liver.

Read source

biopharmadive.com /3 days ago

Merck KGaA bets on RNAi with $1.3B Silence buyout

The acquisition gives the German company a promising blood disorder medicine that passed a Phase 2 test and could threaten a Takeda drug.

Read source

biopharmadive.com /4 weeks ago

RNAi drug specialist ADARx raises $446M IPO

ADARx is the only maker of RNA-based drugs to go public since 2024 and the first RNAi biotech to price an IPO in the U.S. in more than a decade.

Read source

medcitynews.com /3 weeks ago

Gene Silencing-Biotech ADARx Makes Some Noise With $535M Stock Market Debut

ADARx Pharmaceuticals upsized its IPO and raised additional cash through a private placement with partner AbbVie. Lead ADARx program onvuzosiran is in Phase 3 testing for the rare...

Read source

biopharmadive.com /1 week ago

Experimental Arrowhead RNAi drug hints at Alzheimer’s benefit

In a first, a subcutaneously administered RNA interference medicine crossed into the brain and plummeted levels of a protein implicated in the disease.

Read source

journals.plos.org /1 month ago

Non-coding RNA 7SK drives tumor resistance by coupling local oncogenic activation with global transcriptional repression

by Ping Xu, Zile Luo, Xi Chen, Zhongyang Yuan, Le Cheng, Yi Yang, Hongcheng Lin, Qiong Zhang, Pengfei Qin The conserved non-coding RNA 7SK is a well-established global transcripti...

Read source

journals.plos.org /1 month ago

Post-transcriptional regulation of Profilin-2 by microRNAs and RNA-binding proteins forms a critical regulatory node for...

by Carolyn Sangokoya, Isabella R. Rosso, Rana Ghandehari-Alavijeh, Robert Blelloch Post-transcriptional control by RNA binding proteins (RBPs) and microRNAs play central roles in...

Read source

genengnews.com /1 month ago

Moonwalk to Use $70 Million to Develop RNAi Therapies for Obesity, Cardiometabolic Disease

New financing will help Moonwalk Biosciences expand its pipeline of siRNA medicines targeting adipose tissue while building out its proprietary drug discovery platform. The post Mo...

Read source

medcitynews.com /6 days ago

City Therapeutics’ Upsized IPO Raises $200M to Bring RNAi Drugs Beyond the Liver

City Therapeutics’ lead RNA interference therapy could become an alternative to blockbuster-selling anticoagulants. The company’s technology for designing RNAi drugs and delivering...

Read source

rna-seqblog.com /1 month ago

Avoiding a sticky situation: how cells stop messenger RNAs from clumping together

RNA sequencing reveals how naturally occurring mRNA sequences may reduce harmful RNA aggregation, offering insights into transcriptome stability and the design of mRNA therapeutics...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.